Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan

Biomaterials

Volumn 30, Issue 12, 2009, Pages 2340-2348

  Sheng, Yan ^a   Liu, Changsheng ^a,b   Yuan, Yuan ^c   Tao, Xinyi ^a   Yang, Fan ^b   Shan, Xiaoqian ^c   Zhou, Huanjun ^a   Xu, Feng ^c  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b East China University of Science and Technology   (China)

^c East China University of Science and Technology   (China)

Author keywords

Biodistribution; Long circulating; Polyethylene glycol; Polymeric nanoparticles; Water soluble chitosan

Indexed keywords

6 COUMARINS; BIODISTRIBUTION; BLOOD CIRCULATIONS; COMBINATORIAL COATINGS; COMBINATORIAL DESIGNS; COVALENT ATTACHMENTS; DELIVERY VESICLES; DRUG DELIVERY CARRIERS; IN-VITRO; IN-VIVO; INTRAVENOUS ADMINISTRATIONS; LONG-CIRCULATING; PARTICLE SURFACES; PERITONEAL MACROPHAGES; PHYSICAL ADSORPTIONS; POLY-LACTIC ACIDS; POLYMERIC NANOPARTICLES; SIZE RANGES; SURFACE HYDROPHILICITIES; SURFACE MODIFICATIONS; SUSPENSION STABILITIES; SYNERGISTIC ACTIONS; SYSTEMIC CIRCULATIONS; WATER-SOLUBLE CHITOSAN;

ADSORPTION; ANTIGEN-ANTIBODY REACTIONS; BLOOD; CHITIN; CHITOSAN; CONTROLLED DRUG DELIVERY; DYES; ETHYLENE GLYCOL; MACROPHAGES; NANOPARTICLES; POLYETHYLENE OXIDES; POLYMERS; SURFACE CHEMISTRY; SURFACES; THERMOPLASTICS;

POLYETHYLENE GLYCOLS;

6 COUMARIN; CHITOSAN; CHITOSAN DERIVATIVE; COUMARIN; MACROGOL; N CARBOXY PROPIONYL CHITOSAN SODIUM; NANOPARTICLE; POLYLACTIC ACID; UNCLASSIFIED DRUG; WATER;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; HALF LIFE TIME; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MATERIAL COATING; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; PLASMA CLEARANCE; PRIORITY JOURNAL; SOLUBILITY; SURFACE PROPERTY; SUSPENSION;

ANIMALS; CELLS, CULTURED; CHITOSAN; HUMANS; MALE; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PHAGOCYTES; POLYETHYLENE GLYCOLS; SOLUBILITY;

MUS;

EID: 60549105531     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.12.070     Document Type: Article

References (39)

1. Dong Y.C., and Feng S.S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25 (2004) 2843-2849
2. Munier S., Messai I., Delair T., Verrier B., and Ataman-Onal Y. Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties. Colloid Surf B Biointerfaces 43 (2005) 163-173
3. Li Y.P., Pei Y.Y., Zhang X.Y., Gu Z.H., Zhou Z.H., Yuan W.F., et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Controlled Release 71 (2001) 203-211
4. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
5. Owens III D.E., and Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307 (2006) 93-102
6. Zahr A.S., Davis C.A., and Pishko M.V. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 22 (2006) 8178-8185
7. Stolnik S., Illum L., and Davis S.S. Long circulating microparticulate drug carriers. Adv Drug Delivery Rev 16 (1995) 195-214
8. Alexis F., Pridgen E., Molnar L.K., and Farokhzad O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharmacol 5 (2008) 505-515
9. Chang T.M.S., Powanda D., and Yu W.P. Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation. Artif Cells Blood Substit Immobil Biotechnol 31 (2003) 231-247
10. Fang C., Shi B., Pei Y.Y., Hong M.H., Wu J., and Chen H.Z. In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 27 (2006) 27-36
11. Zhao J., Liu C.S., Yuan Y., Tao X.Y., Shan X.Q., Sheng Y., et al. Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers. Biomaterials 28 (2007) 1414-1422
12. Gref R., Lück M., Quellec P., Marchand M., Dellacherie E., Harnisch S., et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloid Surf B Biointerfaces 18 (2000) 301-313
13. Dunn S.E., Coombes A.G.A., Garnett M.C., Davis S.S., Davies M.C., and Illum L. In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers. J Controlled Release 44 (1997) 65-76
14. Gessner A., Lieske A., Paulke B.R., and Müller R.H. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur J Pharm Biopharm 54 (2002) 165-170
15. Avgoustakis K., Beletsi A., Panagi Z., Klepetsanis P., Karydas A.G., and Ithakissios D.S. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Controlled Release 79 (2002) 123-135
16. Fontana G., Licciardi M., Mansueto S., Schillaci D., and Giammona G. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 22 (2001) 2857-2865
17. Lemarchand C., Gref R., and Couvreur P. Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm 58 (2004) 327-341
18. Jaulin N., Appel M., Passirani C., Barratt G., and Labarre D. Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). J Drug Target 8 (2000) 165-172
19. Passirani C., Barratt G., Devissaguet J.-P., and Labarre D. Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). Pharm Res 15 (1998) 1046-1050
20. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 15 (1998) 1326-1331
21. Sashiwa H., Kawasaki N., Nakayama A., Muraki E., Yamamoto N., and Aiba S. Chemical modification of chitosan. 14: synthesis of water-soluble chitosan derivatives by simple acetylation. Biomacromolecules 3 (2002) 1126-1128
22. Chen C.L., Wang Y.M., Liu C.F., and Wang J.Y. The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation. Biomaterials 29 (2008) 2173-2182
23. Sahoo S.K., Panyam J., Prabha S., and Labhasetwar V. Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Controlled Release 82 (2002) 105-114
24. Wang J., Liu C.S., and Chi P. Aggregate formation and surface activity of partially deacetylated water-soluble chitin. Res Chem Intermed 34 (2008) 169-179
25. Cao S.S., Liu B.L., Deng X.B., Luo R., and Chen H.L. A novel approach for the preparation of acrylate-siloxane particles with core-shell structure. Polym Int 56 (2007) 357-363
26. Mengual O., Meunier G., Cayre I., Puech K., and Snabre P. Characterisation of instability of concentrated dispersions by a new optical analyser: the TURBISCAN MA 1000. Colloids Surf A Physicochem Eng Asp 152 (1999) 111-123
27. Panyam J., Sahoo S.K., Prabha S., Bargar T., and Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles. Int J Pharm 262 (2003) 1-11
28. Win K.Y., and Feng S.S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26 (2005) 2713-2722
29. Zambaux M.F., Bonneaux F., Gref R., Maincent P., Dellacherie E., Alonso M.J., et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Controlled Release 50 (1998) 31-40
30. Boury F., Ivanova T., Panaiotov I., Proust J.E., Bois A., and Richou J. Dynamic properties of poly(dl-lactide) and polyvinyl alcohol monolayers at the air/water and dichloromethane/water interfaces. J Colloid Interface Sci 169 (1995) 380-392
31. Coombes A.G.A., Tasker S., Lindblad M., Holmgren J., Hoste K., Toncheva V., et al. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments. Biomaterials 18 (1997) 1153-1161
32. Lück M., Paulke B.-R., Schröder W., Blunk T., and Müller R.H. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. J Biomed Mater Res Part A 39 (1998) 478-485
33. Illium L., Hunneyball I.M., and Davis S.S. The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages. Int J Pharm 29 (1986) 53-65
34. Roser M., Fischer D., and Kissel T. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 46 (1998) 255-263
35. Peracchia M.T., Vauthier C., Passirani C., Couvreur P., and Labarre D. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. Life Sci 61 (1997) 749-761
36. Kenworthy A.K., Simon S.A., and Mcintosh T.J. Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol). Biophys J 68 (1995) 1903-1920
37. Vonarbourg A., Passirani C., Saulnier P., and Benoit J.-P. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 27 (2006) 4356-4373
38. Peracchia M.T., Fattal E., Desmaële D., Besnard M., Noël J.P., Gomis J.M., et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Controlled Release 60 (1999) 121-128
39. Gèze A., Chau L.T., Choisnard L., Mathieu J.-P., Marti-Batlle D., Riou L., et al. Biodistribution of intravenously administered amphiphilic β-cyclodextrin nanospheres. Int J Pharm 344 (2007) 135-142